A modified formula for calculating low-density lipoprotein cholesterol values
- PMID: 20487572
- PMCID: PMC2890624
- DOI: 10.1186/1476-511X-9-52
A modified formula for calculating low-density lipoprotein cholesterol values
Abstract
Background: The Friedewald formula (FF) is useful for calculating serum low-density lipoprotein cholesterol (LDL-C) values, but has a remarkable deviation and limitation especially in hypertriglyceridemia. We modify the formula which is now more suitable for LDL-C calculation.
Methods: 2180 cases were classified into three groups according to their TG concentrations (A: < 200 mg/dl, n = 1220; B: 200-400 mg/dl, n = 480; C: 400-1000 mg/dl, n = 480). The concentrations of LDL-C were measured or estimated by 1) a direct measurement (DM); 2) the FF; and 3) our modified Friedewald formula (MFF): LDL-C (mg/dl) = Non-HDL-C x 90% - TG x 10%.
Results: Linear regression showed a significant correlation (P < 0.001) between the measured and calculated LDL-C values. Bland-Altman plots indicated that the methods (DM/MFF) were in better agreement than those (DM/FF). The LDL-C/Non-HDL-C ratio in FF calculated values was significantly lower (P < 0.05) than that in MFF or DM values, while no significant difference between MFF and DM was found. In Group A and Group B, 4.26% and 14.79% of the MFF calculated values had more than 20% deviation from those measured by DM. These percentages were significantly lower than those calculated by FF, where 7.30% and 25.63% were observed, respectively (P < 0.01 and P < 0.001). The MFF calculated values were all positive even in Group C.
Conclusions: Compared with the FF calculation, serum LDL-C values estimated by our modified formula are closer to those measured by a direct assay. The modification significantly diminishes the interference caused by hypertriglyceridemia.
Figures



Similar articles
-
The reliability of calculated low-density lipoprotein cholesterol from four different formulas in Thai diabetic patients.J Med Assoc Thai. 2014 Jun;97(6):589-97. J Med Assoc Thai. 2014. PMID: 25137876
-
Comparing a novel equation for calculating low-density lipoprotein cholesterol with the Friedewald equation: A VOYAGER analysis.Clin Biochem. 2019 Feb;64:24-29. doi: 10.1016/j.clinbiochem.2018.10.011. Epub 2018 Oct 24. Clin Biochem. 2019. PMID: 30365923
-
Comparison of friedewald formula and modified friedewald formula with direct homogeneous assay for low density lipoprotein cholesterol estimation.J Coll Physicians Surg Pak. 2014 Jan;24(1):8-12. J Coll Physicians Surg Pak. 2014. PMID: 24411534
-
Rationale for use of non-high-density lipoprotein cholesterol rather than low-density lipoprotein cholesterol as a tool for lipoprotein cholesterol screening and assessment of risk and therapy.Am J Cardiol. 1998 Feb 26;81(4A):26B-31B. doi: 10.1016/s0002-9149(98)00034-4. Am J Cardiol. 1998. PMID: 9526810 Review.
-
How should low-density lipoprotein cholesterol be calculated in 2022?Curr Opin Lipidol. 2022 Aug 1;33(4):237-256. doi: 10.1097/MOL.0000000000000833. Curr Opin Lipidol. 2022. PMID: 35942811 Review.
Cited by
-
The Tehran longitudinal family-based cardiometabolic cohort study sheds new light on dyslipidemia transmission patterns.Sci Rep. 2024 Feb 27;14(1):4739. doi: 10.1038/s41598-024-53504-3. Sci Rep. 2024. PMID: 38413617 Free PMC article.
-
Self-reported Male Infertility and Metabolic Disturbance: A Cross-Sectional Study.Int J Endocrinol Metab. 2023 Apr 29;21(2):e134895. doi: 10.5812/ijem-134895. eCollection 2023 Apr. Int J Endocrinol Metab. 2023. PMID: 37654525 Free PMC article.
-
Influence of Abdominal Obesity on the Lipid-Lipoprotein Profile in Apoprotein E2/4 Carriers: The Effect of an Apparent Duality.J Lipids. 2015;2015:742408. doi: 10.1155/2015/742408. Epub 2015 Oct 28. J Lipids. 2015. PMID: 26605088 Free PMC article.
-
Association between a polymorphic poly-T repeat sequence in the promoter of the somatostatin gene and hypertension.Hypertens Res. 2016 Jun;39(6):467-74. doi: 10.1038/hr.2016.4. Epub 2016 Jan 28. Hypertens Res. 2016. PMID: 26818653
-
Lipids as the link between central obesity and diabetes: perspectives from mediation analysis.BMC Endocr Disord. 2024 Oct 28;24(1):229. doi: 10.1186/s12902-024-01764-5. BMC Endocr Disord. 2024. PMID: 39468602 Free PMC article.
References
-
- Cheng AY, Leiter LA. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Curr Opin Cardiol. 2006;21:400–4. - PubMed
-
- National Cholesterol Education Program (NCEP) Expert Panel. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106:3143–421. - PubMed
-
- Keevil JG, Cullen MW, Gangnon R, McBride PE, Stein JH. Implications of cardiac risk and low-density lipoprotein cholesterol distributions in the United States for the diagnosis and treatment of dyslipidemia: data from National Health and Nutrition Examination Survey 1999 to 2002. Circulation. 2007;115:1363–70. doi: 10.1161/CIRCULATIONAHA.106.645473. - DOI - PubMed
-
- Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499–502. - PubMed
-
- McNamara JR, Cohn JS, Wilson PW, Schaefer EJ. Calculated values for low-density lipoprotein cholesterol in the assessment of lipid abnormalities and coronary disease risk. Clin Chem. 1990;36:36–42. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous